Development and dosimetric verification of static SHArc: Step‐and‐shoot carbon ion arc therapy for LET <sub>d</sub> escalation in pancreatic tumors
This study investigates static SHArc, a step-and-shoot approach for delivering carbon ion arc therapy. While static SHArc can provide dosimetric advantages, particularly in terms of LET<sub>d</sub> distribution, EL selection plays a key role. Improving inter-fraction robustness remains crucial for clinical implementation.
Authors
- Jakob Liermann (ORCID: https://orcid.org/0000-0002-1445-1940)
- Thomas Tessonnier (ORCID: https://orcid.org/0000-0002-8919-4299)
- Filipa Baltazar (ORCID: https://orcid.org/0009-0003-9848-6642)
- Abdallah Qubala (ORCID: https://orcid.org/0000-0002-6526-2453)
- Stewart Mein (ORCID: https://orcid.org/0000-0002-6480-912X)
- Andrea Mairani (ORCID: https://orcid.org/0000-0001-6669-7064)
- Jürgen Debus
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Heidelberger Institut für Radioonkologie (DE)
- National Center for Oncological Hadrontherapy (IT)
- National Center for Tumor Diseases (DE)
- National Institutes for Quantum Science and Technology (JP)
Publication Details
- Journal
- Medical Physics
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/mp.70055
- Citations
- 3
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 4.56